as on December 6, 2025 at 2:29 am IST
Day's High
8.16%
Upside
52 Week's Low
52 Week's High
21.51%
Downside
479.59%
Upside
Check Sangamo Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$168.0M
EPS (TTM)
-0.41
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.69
Industry PE ratio
-0.4116938110749186
PEG Ratio
0EBITDA
-104.7M
Revenue (TTM)
32.9M
Profit Margin
0.00%
Return On Equity TTM
-480.02%
Track how Sangamo Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Sangamo Therapeutics, Inc. in the last 5 years
Lowest (-12.09x)
June 30, 2021
Today (-0.69x)
December 5, 2025
Industry (-0.41x)
December 5, 2025
Highest (-0.31x)
December 31, 2023
Today’s Price to Earnings Ratio: -0.69x
Compare market cap, revenue, PE, and other key metrics of Sangamo Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $168.0M | NA | -0.69 | 0.00% | |
| BUY | $43.7B | 410.81% | -16.34 | -264.83% | |
| BUY | $62.5B | 258.57% | 1690.32 | 1.36% | |
| BUY | $118.7B | 100.27% | 30.49 | 31.35% | |
| BUY | $76.7B | 46.78% | 17.33 | 32.13% |
The Sangamo Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sangamo Therapeutics, Inc. investment value today
Current value as on today
₹31,030
Returns
Returns from Sangamo Therapeutics, Inc. Stock
Dollar Returns*
₹6,157 (+6.16%)
Based on 15 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 15 analysts, 66.67% of analysts recommend a 'BUY' rating for Sangamo Therapeutics, Inc.. Average target price of $3.25
Get share price movements and forecasts by analysts on Sangamo Therapeutics, Inc..
What analysts predicted
84.92%UPSIDE
Target Price
$3.25
Current Price
$0.49
Analyzed by
15 Analysts
Target
$3.25
Sangamo Therapeutics, Inc. target price $3.25, a slight upside of 84.92% compared to current price of $0.49. According to 15 analysts rating.
Search interest for Sangamo Therapeutics, Inc. Stock has increased by 105% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:105% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, SGMO stock has moved up by 16.2%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 930.9% return, outperforming this stock by 1015.8%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 172.2% return, outperforming this stock by 245.0%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -19.98M → -34.93M (in $), with an average decrease of 74.8% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 18.30M → 581.0K (in $), with an average decrease of 96.8% per quarter
| Organisation | Sangamo Therapeutics, Inc. |
| Headquarters | 501 Canal Blvd, Richmond, CA, United States, 94804 |
| Industry | Health Technology |
| CEO | Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Stephanie J. Seiler CLP | VP and Head of Business Development & Alliance Management |
Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D. | CEO, President & Director |
Mr. Nikunj Jain | VP of Finance, Corporate Controller & Principal Accounting Officer |
Dr. Nathalie Dubois-Stringfellow Ph.D. | Senior VP & Chief Development Officer |
Mr. Gregory Davis Ph.D. | Head of Research & Technology |
Ms. Louise Wilkie | Head of Global Corporate Communications & Investor Relations |
Mr. Phillip Ramsey | Chief Technical Officer |
Mr. David Ojala | Scientist II - Discovery & Translational Research |
Ms. Prathyusha Duraibabu CPA, M.B.A. | Interim Principal Financial Officer |
Mr. Scott B. Willoughby | Senior VP, Chief Legal Officer & Corporate Secretary |
Sangamo Therapeutics, Inc. share price today is $0.49 as on at the close of the market. Sangamo Therapeutics, Inc. share today touched a day high of $0.53 and a low of $0.49.
Sangamo Therapeutics, Inc. share touched a 52 week high of $2.84 on and a 52 week low of $0.38 on . Sangamo Therapeutics, Inc. stock price today i.e. is closed at $0.49,which is 82.75% down from its 52 week high and 27.41% up from its 52 week low.
Sangamo Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Sangamo Therapeutics, Inc. (SGMO) shares with as little as ₹89.927 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.27 in Sangamo Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sangamo Therapeutics, Inc. share’s latest price of $0.49 as on December 6, 2025 at 2:29 am IST, you will get 20.4082 shares of Sangamo Therapeutics, Inc.. Learn more about
fractional shares .